三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
IBI112,具有同类最佳疗效潜力和长间隔给药,优势明显
IBI112,具有同类最佳疗效潜力和长间隔给药,优势明显
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:249KB
图片尺寸:1755*674
同报告图片
/
4
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
所属报告:
信达生物-港股公司研究报告:新时代Pharma代表创新药全领域旗舰-241024(52页).pdf
打包全文图表
相关数据
IBI112(匹康奇拜单抗)作用
fCDnu4bog57nsbvlnosgfCBJTC0xMiB8IElMLTIzIHwgcDM1IHwgcDQwIHwgcDE5IHwg5YiG5rOM5Zug5a2QIHwKfCA6LS06IHwgOi0tOiB8IDotLTogfCA6LS06IHwgOi0tOiB8IDotLTogfCA6LS06IHwKfCDmoJHnqoHnu4bog54gfCB8IHwgfCB8IHwgfAp8IFRoMee7huiDniB8IHwgfCB8IHwgfCBUTkYtzrEsIElGTi3OsyB8CnwgVGgxN+e7huiDniB8IHwgfCB8IHwgfCBJTC0xNywgSUwtMjIgfAoK6LWE5paZ5p2l5rqQ77ya5L+h6L6+55Sf54mpIDIwMjTlubQz5pyI5oqV
收藏
行业数据
2025-03-14
原图定位
查看详情
银屑病机制及IBI112结构
fCDnu4bog57nsbvlnosgfCDliIbms4zlm6DlrZAgICAgICAgfAp8LS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLXwKfCBUaDHnu4bog54gICB8IFRORi3OsSwgTkYtzrMgICAgfAp8IFRoMTfnu4bog54gIHwgSUwtMTcsIElMLTIyIHwKCui1hOaWmeadpea6kO+8muS/oei+vueUn+eJqeWumOe9kS0yMDIz5bm05bqm5Lia57up5rGH5oql77yM5b636YKm56CU56m25omA
收藏
行业数据
2024-10-25
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
CLEAR-1 研究结果显示出匹康奇拜单抗:1)给药间隔长达 12 周一次;2)短期起效明显,疗效优越;3)一年期治疗内可维持长期稳健且强劲的皮肤清洁疗效;4)安全性良好,无新发安全性信号。
行业数据
原图定位
当前图表所属:
信达生物-港股公司研究报告:新时代Pharma代表创新药全领域旗舰-241024(52页).pdf
国内获批胰腺癌药物
IL-2靶点抗体研发格局
股价估值敏感性分析(单位:港元)
信达生物ADC管线布局
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》